In Ecuador, the pharmaceutical intermediate sector faces unique challenges due to the extreme altitude variations between the coast and the Andean highlands. The production of complex medicine precursors requires rigorous temperature control, where traditional oils often fail due to oxidation or contamination, making the adoption of Perfluoropolyether oil essential for maintaining purity.
The local manufacturing environment often struggles with high humidity in coastal regions like Guayaquil, which can accelerate the degradation of standard Liquid cooling systems. This necessitates the use of chemically inert fluids that do not react with atmospheric moisture or pharmaceutical reagents.
Currently, the Ecuadorian market is transitioning from basic mineral oils to high-performance synthetic fluids. As the country aims to increase its domestic production of active pharmaceutical ingredients (APIs), the demand for an efficient electronic testing fluid has grown to support the modernization of automated reactor controls.
